VANCOUVER, British Columbia, July 10, 2019 (GLOBE NEWSWIRE) -- On Thursday, July 11, the Fraser Institute will release a new study on pharmacare in Canada.

Universal Insurance for Pharmaceuticals in Switzerland and the Netherlands spotlights how those two countries provide universal drug coverage and how their systems differ from the single-payer government-run national pharmacare plan released last month and embraced by the Trudeau government.

A news release with additional information will be issued via GlobeNewswire at 5:00 a.m. (Eastern) on July 11.

MEDIA CONTACTS:
Kristina Acri, Senior Fellow
Fraser Institute

To arrange media interviews or for more information, please contact:
Mark Hasiuk, 604-688-0221 ext. 517, mark.hasiuk@fraserinstitute.org

Follow the Fraser Institute on Twitter | Like us on Facebook

The Fraser Institute is an independent Canadian public policy research and educational organization with offices in Vancouver, Calgary, Toronto, and Montreal and ties to a global network of think-tanks in 87 countries. Its mission is to improve the quality of life for Canadians, their families and future generations by studying, measuring and broadly communicating the effects of government policies, entrepreneurship and choice on their well-being. To protect the Institute’s independence, it does not accept grants from governments or contracts for research. Visit www.fraserinstitute.org.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.